Projects } TBK Capital

Nootropics – Boost your Brain Power

Nootropics - also known as smart drugs and cognitive enhancers - improve cognitive function, particularly executive functions, memory, creativity, or motivation, in healthy individuals.

Nootropics  - also known as smart drugs and cognitive enhancers - improve cognitive function, particularly executive functions, memory, creativity, or motivation, in healthy individuals.

The international nootropic capsule market was worth $3.3 billion in 2017 and is growing at an annual growth rate of 11%, and the Nutraceutical product market, propelled by soaring demand for functional foods and beverages, is forecast to reach $285 billion by 2021.

Customers cover all ages from online gamers, students, young corporate employees, sports/athletes, and constant travellers, to an aging population experiencing short term memory loss through to Alzheimer’s, dementia, and other memory disorders.

New Zealand Manufacture and Export 
There is increased worldwide demand for natural non-addictive ways to boost mental performance. Level Up Performance Ltd is a New Zealand company that has developed and formulated a high strength, non-addictive nootropic supplement that increases mental stamina and endurance, helping users increase their ability to absorb, retain and recall information.

Its formulation has been derived from the specific identification and isolation of certain alkaloids at the cellular level. The business has already undertaken internal protocols to protect this Intellectual Property.

Level Up’s vision is to build a sustainable global business around a natural family of products that help people to feel and perform at their best. It is already producing capsule products, and has completed research and development for 3 new ranges that will allow it to expand into other functional food and beverage categories and e-liquids - in which the nootropic can be inhaled as a vapour.

High gross margins allow the business to make a significant commitment to marketing initiatives to stimulate demand and drive on-going sales activities, especially into China and abroad.

Market Validation
Level Up has now completed beta testing of the product and user group trials have reported increased ability to absorb, retain and recall information, heightened mood and social ease, with an overall increase in mental stamina and endurance.

Initial sales have been to affiliates, influencers and 81 pharmacies and health stores. This target market was particularly responsive to Level Up’s marketing initiatives and these have already resulted in increased sales and reorders. Initial interest from China has been received via a letter of intent.

Sales for the next 12 months of full operation are estimated to be $1.3 million. And with an international e-commerce launch in the following year, sales are budgeted to grow to $16.5 million by Year 5.

Capital Raising
The success of Level Up’s initial launch in New Zealand only 12 months ago, has resulted in a shortage of working capital to further launch its products and meet demand. It intends to use the beta testing results to roll out the product into 250 prominent pharmacies and health stores.

The expansion of this base of influencers and advocates will assist to stimulate sales directly through Level Up’s website and other e-commerce channels.

Level Up Performance Limited is seeking to raise a minimum of $500,000 and up to $1 million through the issue of ordinary new shares in the business. At the $1 million level, this will equate to an 18.2% interest in the business.

Funds raised will be used for additional product development testing (14%), sales and marketing (51%) and general administration including the employment of staff and other working capital requirements (35%).

Want to Know More?
If you’d like to know more about this Offer and receive a copy of the Information Memorandum, email me at a.larsen@tbkcapital.co.nz or call me on 027-483-4200.

.............................................................................................................................................................................................................
The above investment is not an offer of financial products that requires disclosure under the Financial Markets Conduct Act 2013 (Act) and is available only to wholesale investors as defined by that Act. It is intended for distribution only to selected people to whom, under the relevant laws, it can be lawfully distributed. It cannot be distributed in any other jurisdiction, or to any other people. It is not an offer or solicitations in any jurisdiction in which such offers or solicitations are not authorised, or in which the person making such offers or solicitations are not qualified to do so, or to any person to whom it is unlawful to make such offers or solicitations. Any representation to the contrary would be unlawful. No action has been taken by any person that would permit a public offering in any jurisdiction where action for that purpose would be required.


King Regards,

Andrew Larsen
TBK Capital Limited
Level 10,120 Albert Street
Auckland 1010, New Zealand
Mobile +64 27 483 4200
Email a.larsen@tbkcapital.co.nz
 

For more information, please click the contact button below to send us a message.

CONTACT US

⇑ back to top